Do nutraceutics play a role in the prevention and treatment of colorectal cancer?

Cancer Metastasis Rev. 2010 Sep;29(3):395-404. doi: 10.1007/s10555-010-9234-3.

Abstract

Colorectal cancer is the third most common cancer worldwide with a 5-year survival of 50%. Current chemotherapeutic regimens used for advanced colorectal cancer provide an average survival of approximately 20 months. Non-toxic agents such as nutraceutics and supplements have been shown to aid in the prevention and adjuvant treatment of colorectal cancer. This article will discuss the epidemiology, progression, prevention, treatment, and recurrence of colorectal cancer and the role of nutraceutics and supplements in the treatment process.

Publication types

  • Review

MeSH terms

  • Animals
  • Colorectal Neoplasms / epidemiology
  • Colorectal Neoplasms / prevention & control*
  • Dietary Supplements*
  • Humans